XH-30002 Capsule Combined With Afatinib Tablets for the Treatment of Squamous Cell Carcinoma

Clinical trial NCT05927844 · UNKNOWN

Trial details

NCT number: NCT05927844
Sponsor: Fujian Cancer Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma

Start date: 2023-06-01
Primary completion: 2025-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.